Probiotic Lactobacilli in Breast Milk and Infant Stool in Relation to Oral Intake During the First Year of Life
Thomas Abrahamsson, Gabriela Sinkiewicz, Ted Jakobsson et al. · Journal of Pediatric Gastroenterology and Nutrition · 2009
OBJECTIVES: This is to identify factors affecting the prevalence of Lactobacillus reuteri in maternal faeces and breast milk and infant faeces after oral supplementation with L reuteri and to assess the influence on microbial ecology, particularly Clostridium difficile and Bifidobacterium colonization. MATERIALS AND METHODS: In this double-blind trial, 232 mothers with a family history of atopic disease were randomized to a daily intake of either L reuteri American-type culture collection (ATCC) 55730 (1 x 10 colony-forming units [CFU]) or placebo for the last 4 weeks of pregnancy. Their babies then continued with the same study product daily from birth until 12 months of age. Bacterial counts and prevalence were assessed in maternal breast milk and faeces and infant faeces, using conventional cultivation methods. RESULTS: The prevalence of L reuteri was higher during the first year of life in the stool samples from infants in the active as compared with the placebo-treated group. The highest prevalence was recorded at 5 to 6 days of age (82% in the treated vs 20% in the placebo group, P < 0.001). Lactobacillus reuteri was isolated from 12% and 2%, respectively, in the colostrum samples (P < 0.05). Breast-feeding seemed to reduce faecal L reuteri counts, although antibiotics did not influence the levels of L reuteri. The administration of L reuteri did not affect bifidobacteria or C difficile colonization. CONCLUSION: Lactobacillus reuteri may be detected in breast milk after oral supplementation to the mother and in almost all infants after oral supplementation during the first year of life, as well as occasionally in many untreated infants.
Cited by 178 works. doi:10.1097/mpg.0b013e31818f091b
Authors
References
- Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial
- Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing
- Developmental microbial ecology of the neonatal gastrointestinal tract
- The intestinal microflora in allergic Estonian and Swedish 2‐year‐old children
- Allergy development and the intestinal microflora during the first year of life
- Screening of Probiotic Activities of Forty-Seven Strains of Lactobacillus spp. by In Vitro Techniques and Evaluation of the Colonization Ability of Five Selected Strains in Humans
- Intestinal microflora of Estonian and Swedish infants
- An Antigenic Analysis of Lactobacillus Acidophilus
- Lactobacillus reuteri as a Therapeutic Agent in Acute Diarrhea in Young Children
- Probiotics and prebiotic galacto-oligosaccharides in the prevention of allergic diseases: A randomized, double-blind, placebo-controlled trial